The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

Autor: Aapro, Matti, De Laurentiis, Michelino, Rea, Dan, Bargallo Rocha, Juan Enrique, Elizalde, Roberto, Landherr, László, Linderholm, Barbro, Mamounas, Eleftherios, Markopoulos, Christos, Neven, Patrick, Petrovsky, Alexander, Rouzier, Roman, Smit, Vincent, Svedman, Christer, Schneider, Daniel, Thomssen, Christoph, Martin, Miguel

Publikováno v: In The Breast June 2017 33:191-199

A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies

Autor: Rini, Brian, Goddard, Audrey, Knezevic, Dejan, Maddala, Tara, Zhou, Ming, Aydin, Hakan, Campbell, Steven, Elson, Paul, Koscielny, Serge, Lopatin, Margarita, Svedman, Christer, Martini, Jean-Francois, Williams, J Andrew, Verkarre, Virginie, Radulescu, Camelia, Neuzillet, Yann, Hemmerlé, Isabelle, Timsit, Marc Olivier, Tsiatis, Athanasios C, Bonham, Michael, Lebret, Thierry, Mejean, Arnaud, Escudier, Bernard

Publikováno v: In The Lancet Oncology June 2015 16(6):676-685

Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study

Autor: Costa, Fernanda Pires, Junior, Eraldo Luis Batista, Zelmanowicz, Alice, Svedman, Christer, Devenz, Gabriela, Alves, Silvana, da Silva, Andrea Simões Martins, Garicochea, Bernardo

Publikováno v: In Clinics July 2009 64(7):641-644

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer.:Journal of Clinical Oncology

Autor: Awada, Ahmad, Ochsenreither, Sebastian, Eefsen, Rikke Loevendahl, Arnold, Dirk, Yachnin, Jeffrey, Pfeiffer, Per, Jungels, Christiane, Greil, Richard, Poulsen, Laurids, Van Cutsem, Eric, Thorsson, Lars, Svedman, Christer, Garcia-Ribas, Ignacio, Collignon, Joelle

Publikováno v: Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. Suppl. 15, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228
Awada, A, Ochsenreither, S, Eefsen, R L, Arnold, D, Yachnin, J, Pfeiffer, P, Jungels, C, Greil, R, Poulsen, L, Van Cutsem, E, Thorsson, L, Svedman, C, Garcia-Ribas, I & Collignon, J 2021, ' Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer. Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. 15. suppl, e16228 . https://doi.org/10.1200/JCO.2021.39.15_suppl.e16228

e16228Background: Interleukin-1 Receptor Accessory Protein (IL1RAP) is expressed on cancer and stromal cells in many solid tumors. CAN04 is a fully humanized IgG1 targeting IL1RAP blocking IL-1α and ? signaling and triggering ADCC. As monotherapy, C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7ca218eaa878e85447af075f89d15432
https://portal.findresearcher.sdu.dk/da/publications/92cc03ef-9e7d-4dec-bd62-d28a792af0f6